Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 8 Amino 2,3 dimethyl imidazo[1,2 a]pyridine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel cyclohexanone-based process for imidazopyridines offers high yield and scalability for gastric acid inhibitors, ensuring cost reduction in API manufacturing.
Patent CN1452621A details a novel cyclohexanone-based route for substituted imidazopyridines, offering superior yields and scalability for gastric acid inhibitor intermediates.